Aberrometry and Straylight Measurements as an Indication for Cataract Surgery
ASICS
ASICS: Aberrometry and Straylight Measurements as an Indication for Cataract Surgery
1 other identifier
observational
100
1 country
1
Brief Summary
Cataracts are a clouding of the lens of the eye. Cataract surgery replaces the cloudy lens with a clear artificial lens. It is one of the leading causes of low vision worldwide. Since cataracts are mostly age-related, the number of patients with cataracts is increasing sharply due to an ageing population. The indication for cataract surgery is currently based on the visual impairment experienced by the patient, a measurement of visual acuity and the ophthalmologist's assessment of the extent to which the clouding of the lens explains the patient's symptoms. It has been said that after cataract surgery, "the world opens up to you". However, about 10% of patients actually experience worse vision after surgery. This amounts to almost a whole month of potentially unnecessary surgery. It is therefore important to develop a more objective indicator for cataract surgery. Our study focuses on measuring the optical quality of the eye before and after cataract surgery. The investigators also ask patients before and after cataract surgery how patients themselves perceive the quality of their vision. The investigators do this with different patient-reported outcomes. The investigators investigate whether the objective measurement of the optical quality of the eye can predict which patients will be satisfied with the cataract surgery. With this, the investigators aim to further improve patient care and prevent unnecessary surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedStudy Start
First participant enrolled
May 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedJuly 3, 2024
February 1, 2024
1.2 years
February 6, 2024
July 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
log(VSX)
preoperative aberrometry measurements, expressed as log(VSX)
From enrollment to one year after cataract surgery
log(s)
preoperative straylight measurements, expressed as log(s)
From enrollment to one year after cataract surgery
preoperative Catquest-9SF score (expressed as Rasch score)
preoperative Catquest-9SF score, expressed as Rasch score
From enrollment to one year after cataract surgery
postoperative Catquest-9SF score (expressed as Rasch score)
postoperative Catquest-9SF score, expressed as Rasch score
From enrollment to one year after cataract surgery
Study Arms (1)
Cataract
Patients with cataract in both eyes
Interventions
Measurement of self-assessed visual function with Catquest-9SF, measurement of ocular aberrations with iTrace (Tracey Technologies), and straylight measurements with C-Quant (Oculus)
Eligibility Criteria
Ophthalmic patients with cataracts in both eyes seeking surgery on them
You may qualify if:
- At least 18 years old,
- Diagnosis of cataract in both eyes,
- Based on informed consent, will undergo cataract surgery in both eyes (not necessarily immediately bilateral),
- Expected best-corrected visual acuity ≥ 0.7 in both eyes,
- Pupil diameter in mydriasis ≥4 mm and
- Implantation of a (standard) monofocal, toric monofocal or (non)toric Extended Depth of Focus artificial lens.
You may not qualify if:
- Insufficient understanding of the Dutch language to comply with study procedures,
- Spherical refraction of ≤-15 dioptres (due to impossibility of measurement with aberrometer),
- Corneal astigmatism of ≥3 dioptres (because of possible effect on reliability of straylight measurement),
- Implantation of a multifocal artificial lens (because the aberrometer \[still\] cannot properly determine the optical quality of this type of artificial lens),
- Cataract surgery of the second eye not performed 3 months after surgery of the first eye,
- Comorbidity (other than cataract) that may significantly affect vision or give prolonged duration of vision recovery, such as Fuchs\' endothelial cell dystrophy, significant macular degeneration, glaucoma, diabetic maculo- or retinopathy, or an experienced cerebral vascular accident,
- A history of eye surgery (such as corneal refractive surgery and phakic lens implantation),
- An increased risk of complicated cataract surgery, such as lens (sub)luxation, brunescent cataract, posterior polar cataract and a history of trauma to the eye,
- Unable to be reliably measured with aberrometer or straylight meter, and
- A peroperative or postoperative complication that significantly affects vision and has not recovered within 3 months of surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amphia Hospitallead
Study Sites (1)
Amphia
Breda, North Brabant, 4818 CK, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nic J Reus, MD, PhD
Amphia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2024
First Posted
February 14, 2024
Study Start
May 6, 2024
Primary Completion
August 1, 2025
Study Completion
November 1, 2025
Last Updated
July 3, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share